Roche (OTCMKTS:RHHBY) Coverage Initiated by Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Roche (OTCMKTS:RHHBYFree Report) in a research note released on Thursday morning, MarketBeat reports. The firm issued a sell rating on the stock.

A number of other analysts also recently commented on RHHBY. Argus reiterated a hold rating on shares of Roche in a report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a sell rating to a hold rating in a report on Friday, May 17th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of Hold and an average target price of $40.00.

View Our Latest Stock Report on RHHBY

Roche Trading Up 0.8 %

RHHBY stock opened at $31.57 on Thursday. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75. Roche has a 12 month low of $29.20 and a 12 month high of $40.48. The firm has a 50-day moving average of $30.97 and a two-hundred day moving average of $33.22.

Institutional Investors Weigh In On Roche

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Saratoga Research & Investment Management increased its stake in Roche by 6.9% in the first quarter. Saratoga Research & Investment Management now owns 2,458,918 shares of the company’s stock valued at $78,489,000 after purchasing an additional 158,482 shares during the period. Pacer Advisors Inc. increased its stake in Roche by 1,937.5% in the fourth quarter. Pacer Advisors Inc. now owns 1,099,659 shares of the company’s stock valued at $39,841,000 after purchasing an additional 1,045,687 shares during the period. OLD National Bancorp IN boosted its holdings in shares of Roche by 2.0% in the third quarter. OLD National Bancorp IN now owns 251,843 shares of the company’s stock valued at $8,619,000 after acquiring an additional 4,956 shares in the last quarter. Hikari Power Ltd boosted its holdings in shares of Roche by 0.8% in the fourth quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock valued at $8,616,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Altrius Capital Management Inc boosted its holdings in shares of Roche by 2.9% in the fourth quarter. Altrius Capital Management Inc now owns 176,001 shares of the company’s stock valued at $6,377,000 after acquiring an additional 4,939 shares in the last quarter.

About Roche

(Get Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

See Also

Analyst Recommendations for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.